Researchers investigating the mechanisms of Dravet syndrome can access high-quality patient-derived iPSC lines through EBiSC.
These well-characterised lines provide valuable tools for studying disease biology, exploring genotype-phenotype relationships, and supporting the development of new therapeutic approaches. By offering access to robust and reproducible stem cell models, EBiSC helps accelerate research into these severe developmental and epileptic encephalopathies.
✅ Patient-derived iPSC lines carrying clinically relevant variants
✅ Quality-controlled and extensively characterised resources
✅ Available to researchers worldwide through the EBiSC catalogue
🔗 Explore EBiSC’s Dravet syndrome iPSC resources here.